| Typicality: | 0.446 |
| Saliency: | 0.421 |
| to erlotinib | 8 | location |
| to the tyrosine kinase inhibitors | 4 | other |
| to methotrexate | 3 | transitive-object |
| mutation → be associated with → sensitivity | 11 |
| mutation → result in → sensitivity | 4 |
| mutation → lead to → sensitivity | 3 |
| mutation → cause → sensitivity | 3 |
| mutation → affect → sensitivity | 3 |
| negative | neutral | positive |
| 0.284 | 0.645 | 0.071 |
| Raw frequency | 24 |
| Normalized frequency | 0.421 |
| Modifier score | 0.550 |
| Perplexity | 494.538 |